Griseofulvin
- Product NDC
- 62135-968
- 11-digit product format
- 621350968
- Labeler code
- 62135
- Product ID
- 62135-968_2589e155-f098-67fc-e063-6294a90a20b8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Griseofulvin (microsize)
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Chartwell RX, LLC.
- Application
- ANDA065200
- Marketing category
- ANDA
- Marketing start
- 2005-03-02
- Substance
- GRISEOFULVIN
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Griseofulvin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GRISEOFULVIN | 125 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 32HRV3E3D5 |
| Rxcui | 239238 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-968-41 | Griseofulvin | 120 mL in 1 BOTTLE | SUSPENSION | 120 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-968 | GRISEOFULVIN (GRISEOFULVIN (MICROSIZE)) SUSPENSION [CHARTWELL RX, LLC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241030_9f7e4ecf-f992-42c5-81ea-91e6587b22a5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62135-968-41 | 62135096841 | 120 mL in 1 BOTTLE (62135-968-41) | 120 ml | 2021-08-26 | 0000-00-00 | No | No | Current |